---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-029912"
form_type: "8-K"
ticker: null
cik: "0001029142"
company_name: "DYNAVAX TECHNOLOGIES CORP"
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T22:44:02.083444+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Dynavax enters sublease with Metagenomi for 75,662 sq ft after Zymergen bankruptcy

## Summary
- Zymergen sublease terminated via Termination Agreement approved by bankruptcy court on Feb 22, 2024.
- New sublease with Metagenomi for entire premises at 5959 Horton St, Emeryville, initial monthly rent $493,354.
- Rent abated 50% through June 30, 2024; term runs through March 31, 2031, concurrent with master lease.
- Master Landlord consented on March 7, 2024; Sublease to be filed with Q1 2024 10-Q.

## SEC filing metadata
- accession: 0000950170-24-029912
- form_type: 8-K
- cik: 0001029142
- company_name: DYNAVAX TECHNOLOGIES CORP
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1029142/000095017024029912/0000950170-24-029912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1029142/000095017024029912/dvax-20240307.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-029912
- JSON: https://secwatch.observer/filing/0000950170-24-029912.json
- Plain text: https://secwatch.observer/filing/0000950170-24-029912.txt

## Key facts
- Material Agreements
  DYNAVAX TECHNOLOGIES CORP entered into Office/Laboratory Lease with Emery Station West, LLC valued at lease of approximately 75,662 sq ft at 5959 Horton Street, Emeryville, California (effective 2018-09-17).
  - Action: entry
  - Agreement: lease
  - Counterparty: Emery Station West, LLC
  - Value: lease of approximately 75,662 sq ft at 5959 Horton Street, Emeryville, California
  - Effective: 2018-09-17
  source text: on September 17, 2018, Dynavax Technologies Corporation (the “Company”) entered into an Office/Laboratory Lease (“Master Lease”) with Emery Station West, LLC (“Master Landlord”) to lease approximately 75,662 square feet of office/laboratory space located at 5959 Horton Street, Emeryville, California (“Premises”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1029142/000095017024029912/0000950170-24-029912-index.htm
- Material Agreements
  DYNAVAX TECHNOLOGIES CORP terminated Termination and Release Agreement with Zymergen Inc. and Metagenomi, Inc. valued at termination of Zymergen Sublease effective upon satisfaction of conditions precedent (effective 2024-02-22).
  - Action: termination
  - Agreement: lease
  - Counterparty: Zymergen Inc. and Metagenomi, Inc.
  - Value: termination of Zymergen Sublease effective upon satisfaction of conditions precedent
  - Effective: 2024-02-22
  source text: the Company, Zymergen and Metagenomi, Inc. (“Metagenomi”) entered into that certain Termination and Release Agreement dated February 22, 2024 (the “Termination Agreement”), pursuant to which the Zymergen Sublease will terminate effective as of the date the conditions precedent set forth in the Termination Agreement have been satisfied.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1029142/000095017024029912/0000950170-24-029912-index.htm
- Material Agreements
  DYNAVAX TECHNOLOGIES CORP entered into Sublease with Metagenomi, Inc. valued at initial monthly base rate $493,354.08 with 50% abatement through June 30, 2024, term through March 3 (effective 2024-03-07).
  - Action: entry
  - Agreement: lease
  - Counterparty: Metagenomi, Inc.
  - Value: initial monthly base rate $493,354.08 with 50% abatement through June 30, 2024, term through March 3
  - Effective: 2024-03-07
  source text: On March 7, 2024, the Company, as sublandlord, entered into a sublease (the “Sublease”) with Metagenomi, as subtenant, for the Premises.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1029142/000095017024029912/0000950170-24-029912-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.